2023年12月期 第１四半期決算短信〔ＩＦＲＳ〕（連結）

This document is the financial results report for the first quarter of the fiscal year ending December 2023 for GNI Group, Inc. It covers the consolidated performance from January 1 to March 31, 2023. The report indicates an increase in revenue compared to the same period last year, although operating profit has decreased. Key factors include the impact of COVID-19 in China and rising raw material costs. Additionally, increased financial costs related to fundraising by the U.S. subsidiary have affected profits. The company aims to maintain a healthy financial position while focusing on the progress of clinical trials and the development of new products for future growth.